1,086 material Form 8-K filings that 883 companies we cover made with the SEC in July 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
FTI Consulting reported second quarter 2025 revenues of $943.7 million, down 0.6% from $949.2 million a year earlier, and diluted EPS of $2.13 versus $2.34. The company also updated full year 2025 guidance, lowering the GAAP EPS range to $7.24 to $7.84, which includes a first quarter special charge, so shareholders face lower reported earnings than the prior year quarter.
Q2 2025 net income was $71.7 million, compared with $83.9 million in the prior year quarter.
Adjusted EBITDA was $111.6 million, or 11.8% of revenues, versus $115.9 million, or 12.2%, a year earlier.
Full year 2025 revenue guidance is $3.660 billion to $3.760 billion; GAAP EPS guidance is $7.24 to $7.84 and Adjusted EPS guidance is $7.80 to $8.40.
The company repurchased 2,192,333 shares for $354.9 million in the quarter, with $309.3 million left under its repurchase program.
HCA Healthcare reported second-quarter 2025 revenue of $18.605 billion, up 6.4% from a year earlier, and net income attributable to the company of $1.653 billion, or $6.83 per diluted share, up 23.5%. The company raised its 2025 guidance, with diluted EPS now expected at $25.50 to $27.00, up from $24.05 to $25.85. The Board also declared a $0.72 per share quarterly dividend payable September 30, 2025.
Revenue of $18.605 billion, up 6.4% from $17.492 billion; net income attributable to HCA of $1.653 billion versus $1.461 billion
Adjusted EBITDA of $3.849 billion, up 8.4%; operating cash flow of $4.210 billion versus $1.971 billion a year earlier
Revised 2025 guidance: revenue $74.00 billion to $76.00 billion; net income attributable to HCA $6.11 billion to $6.48 billion; Adjusted EBITDA $14.70 billion to $15.30 billion
Quarterly dividend of $0.72 per share, record date September 16, 2025, payment date September 30, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.